Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
-
Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference
-
Adverum Biotechnologies to Participate in Upcoming Investor Conferences
-
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
-
Synlogic to Participate in Chardan’s Genetic Medicines Conference
-
Sensorion Announces Webconference on September 25, 2023, and its Participation in Upcoming Investor Conferences in October 2023
-
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
-
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Prime Medicine to Present at Upcoming Investor Conferences
-
4DMT to Participate in Upcoming Investor Conferences
-
Genenta to Present at Upcoming Scientific and Investor Conferences
-
Myeloid Therapeutics to Participate at Upcoming Investor Conferences
-
Form SC 13D Gardiner Healthcare Acqu Filed by: Chardan Gardiner LLC
-
Abata Therapeutics to Present and Participate in Upcoming Investor and Industry Events
-
CORRECTING and REPLACING Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Arcturus Therapeutics to Attend Upcoming Investor Conferences
-
Lendway, Inc. Announces Second Quarter 2023 Financial Results
-
Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023
-
Allurion Debuts as a Publicly Traded Company on the NYSE
-
Inpixon (INPX) Enters into Definitive Merger Agreement with XTI Aircraft Company
-
Better Therapeutics (BTTX) Announces $6.7M Financing at $0.77/sh
-
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
-
Inpixon Enters into Definitive Merger Agreement with XTI Aircraft Company, Developer of a Vertical Lift Crossover Airplane (VLCA)
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Chardan Capital Markets Starts 4D Molecular Therapeutics (FDMT) at Buy
-
Sonnet BioTherapeutics (SONN) Prices 5M Share Offering at $0.45/sh
-
Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
-
Dragonfly Energy Announces Closing of $20.0 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option
-
Dragonfly Energy Holdings (DFLI) Prices 10M Share Offering at $2/sh
-
Dragonfly Energy Announces Pricing of $20.0 Million Underwritten Public Offering
-
Chardan Capital Markets Starts Zura Bio (ZURA)Buy
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
Dragonfly Energy Speaks at Rho Motion Seminar Series
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
ANEW MEDICAL (LEAS) to Merge with Redwoods Acquisition Corp (RWOD)
-
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement
-
Zura Bio (ZURA) Completes $80M Financing Deal
-
Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Maintains ‘Buy’ Rating in Latest Chardan Research Report
-
ANEW MEDICAL, INC. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
-
Gardiner Healthcare Acquisitions Corp. Receives Notice Regarding Late Form 10-Q Filing From The Nasdaq Stock Market LLC
-
Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend
-
Presto (PRST) Unlocks $20M of Cash in PIPE Transaction
-
Presto Unlocks Approximately $20M of Cash in PIPE Transaction
-
Dragonfly Energy Reports First Quarter 2023 Financial Results
-
Tenaya Therapeutics Inc (TNYA) PT Lowered to $23 at Chardan Capital Markets, Keeps 'Buy'

